Search

Your search keyword '"Bosse, Tjalling"' showing total 713 results

Search Constraints

Start Over You searched for: Author "Bosse, Tjalling" Remove constraint Author: "Bosse, Tjalling"
713 results on '"Bosse, Tjalling"'

Search Results

1. Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study

2. Deep learning detects premalignant lesions in the Fallopian tube

4. Automated causal inference in application to randomized controlled clinical trials

5. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials

6. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation

7. MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome

8. Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer: BIOEMBRACE

9. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

10. Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines

11. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts

12. p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

14. The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significance

15. Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories

16. Prediction of recurrence risk in endometrial cancer with multimodal deep learning

17. Patterns of cytotoxic T-cell densities in immunogenic endometrial cancers reveal a potential mechanism for differences in immunotherapy efficacy

19. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

21. Prognostic value of molecular classification in stage IV endometrial cancer

25. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma

28. MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome

29. HECTOR: multimodal deep learning predicts recurrence risk in endometrial cancer.

30. FIGO 2023 endometrial cancer staging: too much, too soon?

31. SO019LBA/#875 Molecular features predicts outcomes in multicentric international study of chemoradiation and MRI based image guided brachytherapy for cervical cancer (EMBRACE): final analysis from bioembrace-I

32. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, -2 and -3 trials

33. PR024/#394 Molecular profiling of P53 mutant endometrial cancer reveals distinct subgroups with opportunities for personalized therapeutic approaches

35. Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data

37. Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative

40. Clinical Behavior and Molecular Landscape of Stage I p53-abnormal Low-Grade Endometrioid Endometrial Carcinomas

41. Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis

42. 3408: Ten-year results of the PORTEC-3 trial: adjuvant therapy for women with high-risk endometrial cancer

44. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity

45. QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction

46. MLH1Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome

49. RAD51 as a biomarker for homologous recombination deficiency in high‐grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test.

50. Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer

Catalog

Books, media, physical & digital resources